Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AVITA Medical (RCEL) Retained Earnings (2018 - 2025)

AVITA Medical's Retained Earnings history spans 8 years, with the latest figure at -$408.4 million for Q4 2025.

  • For Q4 2025, Retained Earnings fell 13.5% year-over-year to -$408.4 million; the TTM value through Dec 2025 reached -$408.4 million, down 13.5%, while the annual FY2025 figure was -$408.4 million, 13.5% down from the prior year.
  • Retained Earnings reached -$408.4 million in Q4 2025 per RCEL's latest filing, down from -$396.8 million in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of $8.0 million in Q2 2023 to a low of -$408.4 million in Q4 2025.
  • Average Retained Earnings over 5 years is -$223.2 million, with a median of -$254.4 million recorded in 2022.
  • Peak YoY movement for Retained Earnings: skyrocketed 103.59% in 2022, then crashed 24552.96% in 2025.
  • A 5-year view of Retained Earnings shows it stood at -$235.9 million in 2021, then skyrocketed by 103.23% to $7.6 million in 2022, then tumbled by 4006.77% to -$298.0 million in 2023, then dropped by 20.76% to -$359.8 million in 2024, then fell by 13.5% to -$408.4 million in 2025.
  • Per Business Quant, the three most recent readings for RCEL's Retained Earnings are -$408.4 million (Q4 2025), -$396.8 million (Q3 2025), and -$383.6 million (Q2 2025).